Cologne-based pet health startup mammaly has raised €3 million in a pre-series A funding round. Based on scientific findings, the startup offers up a wide range of pet snacks, giving their human owners the possibility to help maintain their best friends’ health and fitness. The funding will be used to further the company’s geographic footprint as well as push forward with addtional product developments in the form of powders, sprays, and other functional products.
Surrounded by dogs for most of their lives, co-founders Stanislav Nazarenus and Alexander Thelen founded mammaly in response to their desire to do something to help these trusted companions as they aged and began to show declining health related issues.
Collaborating with veterinarians, mammaly has developed a range of snacks that specifically target and help reduce the severity of common aging dog issues such as digestive issues, poor dental health, decaying bones and joints, and skin and coat problems.
Looking at the US market, which saw 12.6 million households add a pet to the family roster, mammaly points to the associated 21% rise in pet supplement sales (up to a whopping $800 million), as a strong validator of its business model.
Mammaly’s €3 million pre-seed funding was provided by Five Seasons Ventures.
“Pet supplements are one of the biggest growth stories of our time, which comes as no surprise, given that the number of pets in Germany and wider Europe is growing rapidly,” commented Five Seasons Ventures’ Niccolo Manzoni. “Mammaly has benefited enormously from this trend, which has been further fuelled by the pandemic, reaching an MoM growth rate of 40 percent.”